+ Follow OFLOXACIN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 370745
[Title] => New ofloxacin to boost treatment compliance
[Summary] =>
Pascual Laboratories recently launched its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
This brand is marketed at 10 percent less than the originator brand in order to encourage treatment compliance among patients.
An enormous problem due to antibiotic-resistant has emerged over the years. This is mainly due to treatment non-compliance, a case where a patient does not complete the recommended course of antibiotic therapy.
[DatePublished] => 2006-11-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 363816
[Title] => New brand of ofloxacin to boost treatment compliance
[Summary] =>
Pascual Laboratories recently launched its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
This brand is marketed at half the price of the originator brand in order to encourage treatment compliance among patients.
An enormous problem due to antibiotic-resistant has emerged over the years. This is mainly because of treatment non-compliance, a case where a patient does not complete the recommended course of antibiotic therapy.
[DatePublished] => 2006-10-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 359182
[Title] => Pascual Lab launches new drug to mark 60th year
[Summary] => In the continuing celebration of their 60th anniversary, Pascual Laboratories is launching its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
Years of extensive clinical experience have demonstrated ofloxacins efficacy in eradicating a wide range of microorganisms which cause upper and lower respiratory tract infections, urinary, and reproductive tract infections.
Several studies have proven ofloxacins efficacy over other antibiotics.
[DatePublished] => 2006-09-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
OFLOXACIN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 370745
[Title] => New ofloxacin to boost treatment compliance
[Summary] =>
Pascual Laboratories recently launched its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
This brand is marketed at 10 percent less than the originator brand in order to encourage treatment compliance among patients.
An enormous problem due to antibiotic-resistant has emerged over the years. This is mainly due to treatment non-compliance, a case where a patient does not complete the recommended course of antibiotic therapy.
[DatePublished] => 2006-11-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 363816
[Title] => New brand of ofloxacin to boost treatment compliance
[Summary] =>
Pascual Laboratories recently launched its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
This brand is marketed at half the price of the originator brand in order to encourage treatment compliance among patients.
An enormous problem due to antibiotic-resistant has emerged over the years. This is mainly because of treatment non-compliance, a case where a patient does not complete the recommended course of antibiotic therapy.
[DatePublished] => 2006-10-19 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[2] => Array
(
[ArticleID] => 359182
[Title] => Pascual Lab launches new drug to mark 60th year
[Summary] => In the continuing celebration of their 60th anniversary, Pascual Laboratories is launching its own brand of ofloxacin, a widely tested and clinically proven antibacterial agent.
Years of extensive clinical experience have demonstrated ofloxacins efficacy in eradicating a wide range of microorganisms which cause upper and lower respiratory tract infections, urinary, and reproductive tract infections.
Several studies have proven ofloxacins efficacy over other antibiotics.
[DatePublished] => 2006-09-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 23, 2006 - 12:00am
October 19, 2006 - 12:00am
September 21, 2006 - 12:00am